Supplementary Figure S2 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
<p>Supplementary Figure 2. PFS analysis in baseline population (C1D1) on TP53 mutations, by treatment arms.</p>
Na minha lista:
Registos relacionados
-
Supplementary Table S2 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
Por: Javier Pascual (15018176)
Publicado em: (2025) -
Supplementary Figure S1 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
Por: Javier Pascual (15018176)
Publicado em: (2025) -
Supplementary Figure S3 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
Por: Javier Pascual (15018176)
Publicado em: (2025) -
Supplementary Figure S4 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
Por: Javier Pascual (15018176)
Publicado em: (2025) -
Supplementary Figure S5 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
Por: Javier Pascual (15018176)
Publicado em: (2025)